Drug
Open Label Selinexor
Open Label Selinexor: highest development phase Phase 2, developed by Karyopharm Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Karyopharm Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Open Label Selinexor NCT03193437 | Phase 2 | Thymoma |
Latest
No recent events.
Follow Open Label Selinexor on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.